Diploma (LON:DPLM) had its price target hoisted by Royal Bank of Canada from GBX 1,280 ($16.73) to GBX 1,400 ($18.29) in a report published on Thursday morning, Digital Look reports. They currently have a sector performer rating on the stock.
A number of other equities analysts have also recently weighed in on DPLM. Peel Hunt reissued a hold rating on shares of Diploma in a report on Monday, August 19th. JPMorgan Chase & Co. began coverage on Diploma in a report on Wednesday, May 29th. They issued an overweight rating and a GBX 1,678 ($21.93) price target for the company. Numis Securities boosted their price target on Diploma from GBX 1,420 ($18.55) to GBX 1,475 ($19.27) and gave the stock a hold rating in a report on Monday, May 13th. Finally, Barclays boosted their price target on Diploma from GBX 1,225 ($16.01) to GBX 1,300 ($16.99) and gave the stock an equal weight rating in a report on Tuesday, May 14th. Six research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Diploma presently has an average rating of Hold and a consensus target price of GBX 1,461 ($19.09).
LON DPLM opened at GBX 1,549 ($20.24) on Thursday. Diploma has a fifty-two week low of GBX 1,144 ($14.95) and a fifty-two week high of GBX 1,654 ($21.61). The stock has a market cap of $1.75 billion and a price-to-earnings ratio of 30.37. The business has a fifty day moving average of GBX 1,465.04 and a 200-day moving average of GBX 1,478.16.
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in North America, Europe, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies consumables and instruments for the diagnostic testing of blood, tissue, and other samples in hospital pathology and life sciences laboratories; electrosurgery and minimally invasive surgery equipment and consumables for use in hospital operating rooms; and surgical medical devices, and related consumables and services to GI endoscopy suites in hospitals and private clinics.
Featured Article: How a Put Option Works
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.